Royce & Associates LP Cytokinetics Inc Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Royce & Associates LP holds 24,250 shares of CYTK stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,250
Previous 14,250
70.18%
Holding current value
$1.13 Million
Previous $772,000
65.8%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$684 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$548 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$452 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$362 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$301 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.39B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...